SPRINGWORKS THERAPEUTICS INC (SWTX)

US85205L1070 - Common Stock

46.065  -0.26 (-0.55%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
26.45M5.45M0.000.0035.00M
Cost Of Goods
N/A422.00KN/AN/AN/A
Gross Profit
N/A5.03MN/AN/AN/A
Operating Expenses
384.07M348.04M280.67M173.47M81.32M
Research and Development
170.58M150.49M146.12M101.68M51.86M
Selling, General, and Administrative Expenses
213.49M197.55M134.55M71.79M29.47M
Operating Income
-359.24M-343.01M-280.67M-173.47M-46.32M
Interest Income/Expense
19.98M17.91M3.40M-290.00K730.00K
Other Income/Expense
N/AN/A-140.00K-150.00K30.00K
Income Before Taxes
-339.08M-325.10M-277.42M-173.91M-45.57M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-339.08M-325.10M-277.42M-173.91M-45.57M
EBITDA
-357.10M-341.35M-279.90M-172.98M-45.97M
 
Per Share Data
EPS Diluted Total Ops
-5.15-5.15-5.21-3.59-1.05
Non GAAP EPS
-5.15-5.15-5.21-3.58-1.05
 
Statistics
Gross Profit Margin
N/A92.25%N/AN/AN/A
Profit Margin
-1281.81%-5968.50%N/AN/A-130.20%
Operating Profit Margin
-1358.05%-6297.28%N/AN/A-132.34%

All data in USD

Charts